Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Enhancing Reading Recovery in Aphasia With tDCS and Phonomotor Therapy

NCT: NCT06891638 · COMPLETED

NCT IDNCT06891638
StatusCOMPLETED
Start Date2025-05-12
Completion2026-02-14

Brief Summary

This study is designed for individuals with aphasia, a language disorder that affects many stroke survivors, making it difficult to read, speak, and understand language. Up to 70% of people with aphasia struggle with reading, which impacts their ability to communicate, work, and engage in daily life. The study aims to test a new approach to reading rehabilitation by combining Phono-Motor Treatment (PMT), a language therapy adapted to improve reading, with transcranial direct current stimulation (tDCS), a safe and painless brain stimulation technique. tDCS delivers a mild electrical current to the brain, which may enhance learning. This study will assess whether adding tDCS to PMT improves reading therapy outcomes.

Frequently Asked Questions

What is Enhancing Reading Recovery in Aphasia With tDCS and Phonomotor Therapy?

Enhancing Reading Recovery in Aphasia With tDCS and Phonomotor Therapy is a clinical trial registered under NCT06891638. Current status: COMPLETED.

What is the status of NCT06891638?

The current status of NCT06891638 (Enhancing Reading Recovery in Aphasia With tDCS and Phonomotor Therapy) is: COMPLETED.

When did Enhancing Reading Recovery in Aphasia With tDCS and Phonomotor Therapy start?

Enhancing Reading Recovery in Aphasia With tDCS and Phonomotor Therapy started on 2025-05-12.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.